Alibaba Health Information Technology Management
Management criteria checks 4/4
Alibaba Health Information Technology's CEO is Difan Shen, appointed in Nov 2023, has a tenure of 1.92 years. total yearly compensation is CN¥7.35M, comprised of 22.6% salary and 77.4% bonuses, including company stock and options. directly owns 0.011% of the company’s shares, worth HK$11.49M. The average tenure of the management team and the board of directors is 3.2 years and 3.2 years respectively.
Key information
Difan Shen
Chief executive officer
CN¥7.4m
Total compensation
| CEO salary percentage | 22.56% |
| CEO tenure | 1.9yrs |
| CEO ownership | 0.01% |
| Management average tenure | 3.2yrs |
| Board average tenure | 3.2yrs |
Recent management updates
Recent updates
Alibaba Health Information Technology Limited's (HKG:241) Popularity With Investors Is Clear
Sep 22
Is Now The Time To Put Alibaba Health Information Technology (HKG:241) On Your Watchlist?
Sep 08Estimating The Intrinsic Value Of Alibaba Health Information Technology Limited (HKG:241)
Aug 25Alibaba Health Information Technology's (HKG:241) Solid Earnings Are Supported By Other Strong Factors
Jul 17Returns Are Gaining Momentum At Alibaba Health Information Technology (HKG:241)
Jun 25Investors Interested In Alibaba Health Information Technology Limited's (HKG:241) Earnings
Jun 12Alibaba Health Information Technology Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 21Is Alibaba Health Information Technology Limited (HKG:241) Potentially Undervalued?
Apr 22Alibaba Health Information Technology Limited's (HKG:241) P/E Is Still On The Mark Following 32% Share Price Bounce
Feb 10Here's Why Alibaba Health Information Technology (HKG:241) Has Caught The Eye Of Investors
Feb 02Alibaba Health Information Technology's (HKG:241) Solid Earnings Have Been Accounted For Conservatively
Dec 19Earnings Tell The Story For Alibaba Health Information Technology Limited (HKG:241) As Its Stock Soars 30%
Oct 18CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | CN¥7m | CN¥2m | CN¥1b |
| Dec 31 2024 | n/a | n/a | CN¥1b |
| Sep 30 2024 | n/a | n/a | CN¥1b |
| Jun 30 2024 | n/a | n/a | CN¥1b |
| Mar 31 2024 | CN¥7m | CN¥2m | CN¥883m |
| Dec 31 2023 | n/a | n/a | CN¥851m |
| Sep 30 2023 | n/a | n/a | CN¥819m |
| Jun 30 2023 | n/a | n/a | CN¥678m |
| Mar 31 2023 | CN¥6m | CN¥1m | CN¥536m |
| Dec 31 2022 | n/a | n/a | CN¥332m |
| Sep 30 2022 | n/a | n/a | CN¥128m |
| Jun 30 2022 | n/a | n/a | -CN¥69m |
| Mar 31 2022 | CN¥6m | CN¥1m | -CN¥266m |
| Dec 31 2021 | n/a | n/a | -CN¥216m |
| Sep 30 2021 | n/a | n/a | -CN¥167m |
| Jun 30 2021 | n/a | n/a | CN¥91m |
| Mar 31 2021 | n/a | n/a | CN¥349m |
| Dec 31 2020 | n/a | n/a | CN¥313m |
| Sep 30 2020 | n/a | n/a | CN¥278m |
| Jun 30 2020 | n/a | n/a | CN¥136m |
| Mar 31 2020 | CN¥12m | CN¥2m | -CN¥7m |
| Dec 31 2019 | n/a | n/a | -CN¥3m |
| Sep 30 2019 | n/a | n/a | CN¥1m |
| Jun 30 2019 | n/a | n/a | -CN¥40m |
| Mar 31 2019 | CN¥7m | CN¥33k | -CN¥82m |
Compensation vs Market: Difan's total compensation ($USD1.03M) is about average for companies of similar size in the Hong Kong market ($USD824.61K).
Compensation vs Earnings: Difan's compensation has been consistent with company performance over the past year.
CEO
Difan Shen (47 yo)
Mr. Difan Shen serves as Chief Executive Officer of Alibaba Health Information Technology Limited from November 28, 2023 and serves as Executive Director since October 13, 2021. He was Chief Operating Offi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 1.9yrs | CN¥7.35m | 0.011% HK$ 11.5m | |
| CFO & Executive Director | 5.5yrs | CN¥4.56m | 0.0061% HK$ 6.4m | |
| Legal Counsel & Joint Company Secretary | 2.8yrs | no data | no data | |
| Chief Marketing Officer | 3.6yrs | no data | no data | |
| Chief People Officer | 5.7yrs | no data | no data | |
| Financial Controller | no data | no data | no data | |
| Chief Legal Advisor & Joint Company Secretary | 2.2yrs | no data | no data |
Experienced Management: 241's management team is considered experienced (3.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 4yrs | CN¥7.35m | 0.011% HK$ 11.5m | |
| CFO & Executive Director | 5yrs | CN¥4.56m | 0.0061% HK$ 6.4m | |
| Independent Non-Executive Director | 2.2yrs | CN¥646.00k | no data | |
| Independent Non-Executive Director | 6.3yrs | CN¥350.00k | no data | |
| Non-Executive Chairman of the Board | 5.6yrs | CN¥27.21m | 0.011% HK$ 11.1m | |
| Independent Non-Executive Director | 2.2yrs | CN¥350.00k | no data | |
| Non-Executive Director | 2.4yrs | no data | no data | |
| Non-Executive Director | 2yrs | no data | no data |
Experienced Board: 241's board of directors are considered experienced (3.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/06 05:32 |
| End of Day Share Price | 2025/10/06 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Alibaba Health Information Technology Limited is covered by 30 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xiaomeng Zhuang | BofA Global Research |
| Shun Kei Law | CCB International Securities Limited |
| Hazim Bahari | CFRA Equity Research |